Yardley, Pennsylvania
United States
13
2021-10-28
The entities that hold a legal rights for patent applications filed by inventor SHAW Peter:
Peter SHAW from Yardley, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#2 | 2018-10-25Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#3 | 2017-02-02Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
#4 | 2014-08-07GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
#5 | 2010-07-29GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF
#6 | 2009-03-17Methods of using EPHA2 for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
#7 | 2008-12-25Methods for determining sensitivity to microtubule-stabilizing agents comprising ixabepilone by measuring the level of estrogen receptor 1
#8 | 2007-07-19Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways
#9 | 2006-06-08Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
#10 | 2006-03-02Identification of polynucleotides and polypetide for predicting activity of compounds that interact with protein tyrosine kinase and or protein tyrosine kinase pathways
#11 | 2006-02-09Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
#12 | 2006-01-26Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in lung cancer cells
#13 | 2005-12-08Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
864270 ⎘